PCK 5.56% 3.4¢ painchek ltd

EPAT General Discussion, page-983

  1. 330 Posts.
    lightbulb Created with Sketch. 57
    I believe the market is expecting two things this quarter:
    1. FDA approval
    2. Full national roll out of one of the RACs

    2018 will be a rewarding year for holders.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.